Daniel D. Burton - Feb 20, 2024 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Executive Officer, Director
Signature: /s/ Benjamin Landry, as Attorney-in-Fact
Stock symbol: HCAT
Transactions as of: Feb 20, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/22/2024, 07:34 PM
Previous filing: Dec 5, 2023
Next filing: Feb 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Award	$0	+250K	+27.89%	$0.00	1.15M	Feb 20, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.

Content

Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.